DE69623619D1 - Ophthalmische emulsionen mit verzoegerter freisetzung - Google Patents

Ophthalmische emulsionen mit verzoegerter freisetzung

Info

Publication number
DE69623619D1
DE69623619D1 DE69623619T DE69623619T DE69623619D1 DE 69623619 D1 DE69623619 D1 DE 69623619D1 DE 69623619 T DE69623619 T DE 69623619T DE 69623619 T DE69623619 T DE 69623619T DE 69623619 D1 DE69623619 D1 DE 69623619D1
Authority
DE
Germany
Prior art keywords
delayed
emulsions
dispersed phase
release ophthalmic
ophthalmic emulsions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69623619T
Other languages
English (en)
Inventor
M Bowman
A Patel
B Ottoboni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Inc
Original Assignee
Insite Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insite Vision Inc filed Critical Insite Vision Inc
Application granted granted Critical
Publication of DE69623619D1 publication Critical patent/DE69623619D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69623619T 1995-06-07 1996-05-29 Ophthalmische emulsionen mit verzoegerter freisetzung Expired - Lifetime DE69623619D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/488,675 US5767153A (en) 1995-06-07 1995-06-07 Sustained release emulsions
PCT/US1996/008119 WO1996040051A1 (en) 1995-06-07 1996-05-29 Sustained release ophthalmic emulsions

Publications (1)

Publication Number Publication Date
DE69623619D1 true DE69623619D1 (de) 2002-10-17

Family

ID=23940673

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69623619T Expired - Lifetime DE69623619D1 (de) 1995-06-07 1996-05-29 Ophthalmische emulsionen mit verzoegerter freisetzung

Country Status (7)

Country Link
US (2) US5767153A (de)
EP (1) EP0831775B1 (de)
AT (1) ATE223698T1 (de)
AU (1) AU5884996A (de)
DE (1) DE69623619D1 (de)
DK (1) DK0831775T3 (de)
WO (1) WO1996040051A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
EP1020194A4 (de) 1997-10-01 2003-05-21 Wakamoto Pharma Co Ltd Öl/wasser emulsion zusammenstellungen
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US7141607B1 (en) * 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
ES2431640T3 (es) * 2003-08-21 2013-11-27 Sucampo Ag Composición oftálmica que comprende éster isopropílico de unoprostona y un agente de viscosidad
DE602004023106D1 (de) * 2003-11-07 2009-10-22 Senju Pharma Co Pharmazeutische zusammensetzung mit prostaglandin
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
ATE412400T1 (de) * 2004-11-09 2008-11-15 Novagali Pharma Sa Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
CA2631497C (en) * 2005-12-05 2014-04-22 Bioartificial Gel Technologies Inc. Emulsions of a protein-crosslinked hydrogel matrix and dispersed hydrophobic phase
US9132071B2 (en) * 2006-07-28 2015-09-15 Santen Sas Compositions containing quaternary ammonium compounds
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
US20080026013A1 (en) * 2006-07-28 2008-01-31 Laura Rabinovich-Guilatt Compositions containing quaternary ammonium compounds
US20080171790A1 (en) * 2007-01-12 2008-07-17 Filiberto Palmiro Zadini Fatty acids-systemic lipid solubilizers conjugates
EP2066309B1 (de) 2007-04-04 2012-08-29 Sigmoid Pharma Limited Orale pharmazeutische zusammensetzung
EP2389939A1 (de) 2010-05-28 2011-11-30 Novagali Pharma S.A. Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE6466T1 (de) * 1979-10-26 1984-03-15 Smith And Nephew Associated Companies P.L.C. Autoklavierbare emulsionen.
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
DE69328368T2 (de) * 1992-08-28 2000-08-10 Pharmos Corp., New York Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery

Also Published As

Publication number Publication date
AU5884996A (en) 1996-12-30
US5767153A (en) 1998-06-16
DK0831775T3 (da) 2002-10-07
US5977171A (en) 1999-11-02
EP0831775A1 (de) 1998-04-01
WO1996040051A1 (en) 1996-12-19
ATE223698T1 (de) 2002-09-15
EP0831775B1 (de) 2002-09-11

Similar Documents

Publication Publication Date Title
DE69623619D1 (de) Ophthalmische emulsionen mit verzoegerter freisetzung
DE69424275D1 (de) Alkalische ophthalmische suspensionen
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
DE59608732D1 (de) Lagerstabile arzneiformen
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
ATE220541T1 (de) Feste wirkstoff-zubereitungen
IS2036B (is) Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi
DE69721489D1 (de) Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen
BR9713414A (pt) Processo para a preparação de uma dispersão de polìmero.
DK0607118T3 (da) System til administrering af phospholipid
NO176696C (no) Fremgangsmåte for fremstilling av henholdsvis et medikamentavleveringssystem og et tåreerstatningssystem
EP0617972A3 (de) Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)-acrylat-Mischung
ATE52027T1 (de) Formulierungen mit verzoegerter freisetzung.
NO964939D0 (no) Fremgangsmåte for fremstilling av virkestoffpreparater i form av en fast lösning av virkestoffet i en polymermatriks, samt virkestoffpreparater fremstilt ved hjelp av denne fremgangsmåte
DK0797435T3 (da) Matrice til kontrolleret frigivelse af lægemidler
KR950005301A (ko) 방출 개시 제어 및 방출 속도 제어형 제제
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
SE442997B (sv) Forfarande utgorande av forfarandet enligt krav 1 i se,b, 432 770 varvid till den homogeniserade blandningen en oljeloslig polymerisationsinitiator tillsettes, vilken har en vattenloslighet som medger att den kan diffun
ES523586A0 (es) "metodo de preparacion de una composicion contraceptiva para administracion vaginal"
NO307952B1 (no) Oftalmologisk preparat samt fremgangsmÕte til fremstilling derav
AR012723A1 (es) Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos
ATE194489T1 (de) Bioerodierbares system zur kontrollierten freigabe
Tulunay et al. The effects of morphine and Δ-9-tetrahydrocannabinol on motor activity in rats
NZ331051A (en) Instant release forms of gelled active substances
ES2160723T3 (es) Polimeros de poli(alcohol vinilico) sulfatados para estabilizar compuestos farmaceuticos.

Legal Events

Date Code Title Description
8332 No legal effect for de